XFRA NEW INSTRUMENTS AVAILABLE ON XETRA

Realtime	Geld	Brief	Zeit
	0,000	0,000	16.10.

Realtime

Geld

Brief

Zeit

0,000

16.10.

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 03.09.2024

The following instruments on XETRA do have their first trading 03.09.2024
Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 03.09.2024

Aktien

1 AU000000ICI5 iCandy Interactive Ltd.

2 CA75941A1012 Rektron Group Inc.
3 US5768103039 Matinas BioPharma Holdings Inc.
4 US6876041087 Oruka Therapeutics Inc.
5 BE0974487192 Oxurion N.V.

Anleihen/ETF

1 EU000A1Z99U9 Europäischer Stabilitätsmechanismus [ESM]
2 ES0L02505094 Spanien, Königreich
3 IT0005611139 CDP RETI S.p.A.
4 IT0005611063 Mediobanca - Banca di Credito Finanziario S.p.A.
5 XS2895057094 BMW International Investment B.V.
6 IT0005611055 Italien, Republik
7 LU2868143954 BNP Paribas Easy JPM ESG EMBI Global Diversified Composite UCITS ETF H CHF
8 LU2868144093 BNP Paribas Easy JPM ESG EMBI Global Diversified Composite UCITS ETF H GBP

Nach Nvidia: 5 KI-Revolutionäre aus der zweiten Reihe!

Künstliche Intelligenz hat spätestens nach dem Raketenstart von Chat GPT das Leben aller verändert. Doch der Superzyklus steht nach Meinungen von Experten erst am Anfang. Während Aktien wie Nvidia von der ersten Aufwärtsentwicklung stark profitieren konnten, versprechen aussichtsreiche Player aus der

zweiten Reihe noch enormes Aufwärtspotenzial.

Im kostenlosen, exklusiven Spezialreport präsentieren wir ihnen 5 innovative KI-Unternehmen, die bahnbrechende Entwicklungen in diesem Sektor prägen könnten.

Warum sollten Sie dabei sein?
Trotz der jüngsten Erfolge steht die Entwicklung der künstlichen Intelligenz noch am Beginn eines neuen Superzyklus. Experten gehen davon aus, dass der Sektor bis 2032 global auf 1,3 Billionen US-Dollar explodieren wird, wobei ein großer Teil auf Hardware und Infrastruktur entfallen wird.

Nutzen Sie die Chance!
Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche 5 KI-Aktien das größte Potenzial zur Vervielfachung besitzen. Dieser Report ist komplett kostenlos und zeigt Ihnen die aussichtsreichsten Investments im KI-Sektor.
Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Hier klicken

Zeit	Aktuelle Nachrichten
03.11.	ICANDY INTERACTIVE LIMITED: ICI initiates legal action on former lemon sky executives
28.10.	ICANDY INTERACTIVE LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report
25.09.	ICANDY INTERACTIVE LIMITED: Notification of cessation of securities - ICI
03.09.	XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 03.09.2024	The following instruments on XETRA do have their first trading 03.09.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 03.09.2024 Aktien 1 AU000000ICI5 iCandy Interactive Ltd. 2... ► Artikel lesen
30.08.	ICANDY INTERACTIVE LIMITED: Half Yearly Report and Accounts

Zeit

Aktuelle Nachrichten

03.11.

ICANDY INTERACTIVE LIMITED: ICI initiates legal action on former lemon sky executives

28.10.

ICANDY INTERACTIVE LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report

25.09.

ICANDY INTERACTIVE LIMITED: Notification of cessation of securities - ICI

03.09.

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 03.09.2024

The following instruments on XETRA do have their first trading 03.09.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 03.09.2024 Aktien 1 AU000000ICI5 iCandy Interactive Ltd. 2...
► Artikel lesen

30.08.

ICANDY INTERACTIVE LIMITED: Half Yearly Report and Accounts

Zeit	Aktuelle Nachrichten
Mi	Matinas BioPharma Holdings, Inc. - 10-Q, Quarterly Report
06.11.	MTNB stock touches 52-week low at $0.5 amid sharp annual decline
06.11.	MTNB-Aktie erreicht 52-Wochen-Tief bei 0,5 US-Dollar
31.10.	Matinas BioPharma mulls wind-down as antifungal therapy deal falls through
31.10.	Matinas BioPharma plunges as deal for lead asset falls apart

Zeit

Aktuelle Nachrichten

Matinas BioPharma Holdings, Inc. - 10-Q, Quarterly Report

06.11.

MTNB stock touches 52-week low at $0.5 amid sharp annual decline

06.11.

MTNB-Aktie erreicht 52-Wochen-Tief bei 0,5 US-Dollar

31.10.

Matinas BioPharma mulls wind-down as antifungal therapy deal falls through

31.10.

Matinas BioPharma plunges as deal for lead asset falls apart

Zeit	Aktuelle Nachrichten
Do	Oruka Therapeutics, Inc. - 8-K, Current Report
Do	Oruka Therapeutics files to sell 8.72M shares of common stock for holders
Do	Oruka Therapeutics, Inc. - S-1, General form for registration of securities
Do	Oruka Therapeutics GAAP EPS of -$1.46 misses by $1.08
Mi	Oruka Therapeutics, Inc.: Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update	Successful go-public transaction and over $475 million raised this year provides cash runway through multiple clinical inflection points ORKA-001 non-human primate (NHP) pharmacokinetic and in vitro... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Oruka Therapeutics, Inc. - 8-K, Current Report

Oruka Therapeutics files to sell 8.72M shares of common stock for holders

Oruka Therapeutics, Inc. - S-1, General form for registration of securities

Oruka Therapeutics GAAP EPS of -$1.46 misses by $1.08

Oruka Therapeutics, Inc.: Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Successful go-public transaction and over $475 million raised this year provides cash runway through multiple clinical inflection points ORKA-001 non-human primate (NHP) pharmacokinetic and in vitro...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Do	OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC	Leuven, BELGIUM - November 14, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen
05.11.	OXURION: Oxurion terminates its Private Judicial Reorganization Procedure following amicable settlement agreements	Leuven, Belgium - November 5, 2024 - 10:30 AM CET - Oxurion NV (Euronext Brussels: OXUR) announces that it terminated the private judicial reorganization (PRJ) procedure initiated on August 22... ► Artikel lesen
29.10.	OXURION: Oxurion NV: Key developments and timeline for current the potential acquisition	Oxurion NV: Belangrijkste ontwikkelingen en lijn met betrekking tot de lopende potentiële overname LEUVEN, BELGIË - 29 oktober 2024 - 22u00 CET, Oxurion NV (Euronext Brussels: OXUR), een biofarmaceutisch... ► Artikel lesen
24.10.	OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC	Leuven, BELGIUM - October 24, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen
14.10.	OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC	Leuven, BELGIUM - October 14, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen

Zeit

Aktuelle Nachrichten

OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Leuven, BELGIUM - November 14, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen

05.11.

OXURION: Oxurion terminates its Private Judicial Reorganization Procedure following amicable settlement agreements

Leuven, Belgium - November 5, 2024 - 10:30 AM CET - Oxurion NV (Euronext Brussels: OXUR) announces that it terminated the private judicial reorganization (PRJ) procedure initiated on August 22...
► Artikel lesen

29.10.

OXURION: Oxurion NV: Key developments and timeline for current the potential acquisition

Oxurion NV: Belangrijkste ontwikkelingen en lijn met betrekking tot de lopende potentiële overname LEUVEN, BELGIË - 29 oktober 2024 - 22u00 CET, Oxurion NV (Euronext Brussels: OXUR), een biofarmaceutisch...
► Artikel lesen

24.10.

OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Leuven, BELGIUM - October 24, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen

14.10.

OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Leuven, BELGIUM - October 14, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen

Zeit	Aktuelle Nachrichten
01.11.	Rektron Group Inc.: Rektron Announces Signing of a Share Purchase Agreement to Sell Itssubsidiary Inland Shipping and Supply Ltd. and a Corporate Update	NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / November 1, 2024 / Rektron Group Inc. ("Rektron" or the "Company") (CSE:REK.U)(FRA:F75) a... ► Artikel lesen
01.11.	Rektron Group Inc: Rektron Group non-venture designation
01.11.	CSE Bulletin: NV Issuer Designation - Rektron Group Inc. (REK.U)	Toronto, Ontario--(Newsfile Corp. - Le 1 novembre/November 2024) - CSE has determined that Rektron Group Inc. has met the criteria set out in CSE Policy 2A.4 for an NV Issuer. Listed Issuers designated... ► Artikel lesen
29.10.	Rektron Group Inc.: Rektron Announces Change of Auditor	NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / October 28, 2024 / Rektron Group Inc. ("Rektron" or the "Company") (CSE:REK.U)(FRA:F75) a... ► Artikel lesen
25.10.	Rektron Group Inc.: Rektron Announces Signing of an Exit Agreement With Its Significant Shareholders	NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / October 25, 2024 / Rektron Group Inc. ("Rektron" or the "Company") (CSE:REK.U)(FRA:F75) a... ► Artikel lesen

Zeit

Aktuelle Nachrichten

01.11.

Rektron Group Inc.: Rektron Announces Signing of a Share Purchase Agreement to Sell Itssubsidiary Inland Shipping and Supply Ltd. and a Corporate Update

NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / November 1, 2024 / Rektron Group Inc. ("Rektron" or the "Company") (CSE:REK.U)(FRA:F75) a...
► Artikel lesen

01.11.

Rektron Group Inc: Rektron Group non-venture designation

01.11.

CSE Bulletin: NV Issuer Designation - Rektron Group Inc. (REK.U)

Toronto, Ontario--(Newsfile Corp. - Le 1 novembre/November 2024) - CSE has determined that Rektron Group Inc. has met the criteria set out in CSE Policy 2A.4 for an NV Issuer. Listed Issuers designated...
► Artikel lesen

29.10.

Rektron Group Inc.: Rektron Announces Change of Auditor

NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / October 28, 2024 / Rektron Group Inc. ("Rektron" or the "Company") (CSE:REK.U)(FRA:F75) a...
► Artikel lesen

25.10.

Rektron Group Inc.: Rektron Announces Signing of an Exit Agreement With Its Significant Shareholders

NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / October 25, 2024 / Rektron Group Inc. ("Rektron" or the "Company") (CSE:REK.U)(FRA:F75) a...
► Artikel lesen

Unternehmen / Aktien	Kurs	%
ICANDY INTERACTIVE LIMITED	0,010	0,00 %
MATINAS BIOPHARMA HOLDINGS INC	0,660	0,00 %
ORUKA THERAPEUTICS INC	22,600	-0,88 %
OXURION NV	0,272	0,00 %
REKTRON GROUP INC	1,400	-2,78 %

Unternehmen / Aktien

Kurs

ICANDY INTERACTIVE LIMITED

0,010

0,00 %

MATINAS BIOPHARMA HOLDINGS INC

0,660

0,00 %

ORUKA THERAPEUTICS INC

22,600

-0,88 %

OXURION NV